跳转至内容
  • Reduced trigeminovascular cyclicity in patients with menstrually related migraine.

Reduced trigeminovascular cyclicity in patients with menstrually related migraine.

Neurology (2014-12-17)
Khatera Ibrahimi, Willebrordus Petrus Johannes van Oosterhout, Wendy van Dorp, A H Jan Danser, Ingrid M Garrelds, Steven A Kushner, Emmanuel M E H Lesaffre, G M Terwindt, Michel D Ferrari, Anton H van den Meiracker, Antoinette MaassenVanDenBrink
摘要

A case-control study to investigate the effect of the menstrual cycle on trigeminal nerve-induced vasodilation in healthy women and patients with menstrually related migraine (MRM). Using a laser-Doppler imager, we compared the vasodilator effects of capsaicin application and electrical stimulation (ES) on the forehead skin, a trigeminal nerve-innervated dermatome, in premenopausal patients with MRM (n = 22), healthy controls (n = 20), and postmenopausal women without migraine (n = 22). Blood samples were collected for female sex hormone measurements. Dermal blood flow (DBF) responses to capsaicin were higher in controls during days 1-2 than during days 19-21 of their menstruation cycle (mean Emax ± SEM: 203 ± 28 AU vs 156 ± 27 AU [p = 0.031] for 0.06 mg/mL capsaicin and 497 ± 25 AU vs 456 ± 24 AU [p = 0.009] for 6.0 mg/mL capsaicin). In contrast, patients with MRM demonstrated DBF responses without significant cycle-dependent variability (days 1-2 vs days 19-21: Emax 148 ± 20 AU vs 154 ± 20 AU [p = 0.788] for 0.06 mg/mL capsaicin and 470 ± 17 AU vs 465 ± 20 AU [p = 0.679] for 6.0 mg/mL capsaicin). DBF responses to ES were not different between either patients with MRM or controls, at either occasion. Estradiol levels on days 19-21 of the menstrual cycle were higher in healthy controls (mean ± SEM: 75 ± 8 pg/mL) than in patients with MRM (52 ± 4 pg/mL, p = 0.014). In postmenopausal women, DBF responses to capsaicin and ES, as well as estradiol levels at both visits, were all significantly reduced compared to patients with MRM and controls (in all cases, p < 0.05). Our study provides evidence for a reduced menstrual cyclicity of both estradiol levels and the trigeminovascular vasodilator system in patients with MRM.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
黄体酮, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
黄体酮, ≥99%
Sigma-Aldrich
雌二醇, meets USP testing specifications
Sigma-Aldrich
黄体酮, meets USP testing specifications
Sigma-Aldrich
黄体酮, γ-irradiated, BioXtra, suitable for cell culture
Supelco
黄体酮, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
雌二醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
二喹啉甲酸 二钠盐 水合物, ≥98% (HPLC)
USP
雌二醇, United States Pharmacopeia (USP) Reference Standard
USP
黄体酮, United States Pharmacopeia (USP) Reference Standard
黄体酮, European Pharmacopoeia (EP) Reference Standard
黄体酮, European Pharmacopoeia (EP) Reference Standard
黄体酮, European Pharmacopoeia (EP) Reference Standard
Supelco
黄体酮, VETRANAL®, analytical standard
Sigma-Aldrich
黄体酮, Vetec, reagent grade, 98%
Sigma-Aldrich
二喹啉甲酸 二钠盐 水合物, Vetec, reagent grade, 98%